Topical macrolactams: New indications, potential pitfalls

Cutis

Volumn 73, Issue 4, 2004, Pages 225-227

  Elston, Dirk M ^a  

^a GEISINGER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETAMETHASONE VALERATE; CLOCORTOLONE PIVALATE; CORTICOSTEROID; HYDROCORTISONE ACETATE; HYDROCORTISONE BUTYRATE; LACTAM DERIVATIVE; MACROLACTAM DERIVATIVE; MOMETASONE FUROATE; NICOTINIC ACID METHYL ESTER; PIMECROLIMUS; TERBINAFINE; TSUKUBAENOLIDE; UNCLASSIFIED DRUG; VASODILATOR AGENT;

ATOPIC DERMATITIS; ATROPHY; BACTERIAL SKIN DISEASE; BURNING SENSATION; CRYPTOCOCCOSIS; DERMATOMYCOSIS; DRUG ABSORPTION; DRUG EFFICACY; DRUG PENETRATION; DRUG POTENCY; DRUG POTENTIATION; DRUG SAFETY; DRUG TOLERABILITY; EDITORIAL; FOLLICULITIS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MYCOSIS; POMPHOLYX; PSORIASIS; ROSACEA; SIDE EFFECT; SKIN TINGLING; TINEA; TINEA INCOGNITO; VIRAL SKIN DISEASE;

ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS, LOCAL; HUMANS; LACTAMS; SKIN DISEASES;

EID: 2342532348     PISSN: 00114162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (17)

1. Rappersberger K, Meingassner JG, Fialla R, et al. Clearing of psoriasis by a novel immunosuppressive macrolide. J Invest Dermatol. 1996;106:701-710.
2. Travis LB, Weinberg JM, Silverberg NB. Successful treatment of vitiligo with 0.1% tacrolimus ointment. Arch Dermatol. 2003;139:571-574.
3. Rao NG, Pariser RJ. Annular erythema responding to tacrolimus ointment. J Drugs Dermatol 2003;2:421-424.
4. Thelmo MC, Lang W, Brooke E, et al. An open-label pilot study to evaluate the safety and efficacy of topically applied tacrolimus ointment for the treatment of hand and/or foot eczema. J Dermatol Treat. 2003;14:136-140.
5. Goldman D. Tacrolimus ointment for the treatment of steroid-induced rosacea: a preliminary report. J Am Acad Dermatol. 2001;44:995-998.
6. Fleischer AB Jr, Ling M, Eichenfield L, et al, and the Tacrolimus Ointment Study Group. Tacrolimus ointment for the treatment of atopic dermatitis is not associated with an increase in cutaneous infections. J Am Acad Dermatol. 2002;47:562-570.
7. Kang S, Paller A, Soter N, et al. Safe treatment of head/neck AD with tacrolimus ointment. J Dermatol Treat. 2003;14:86-94.
8. Yamamoto T, Nishioka K. Deep dermatophytosis during topical tacrolimus therapy for psoriasis [letter]. Acta Derm Venereol. 2003;83:291-292.
9. Corales R, Chua J, Mawhorter S, et al. Significant post-transplant hypogammaglobulinemia in six heart transplant recipients: an emerging clinical phenomenon? Transplant Infect Dis. 2000;2:133-139.
10. Martel J, Faisant M, Lebeau B, et al. Subcutaneous mycosis due to Scopulariopsis brevicaulis in an immunocompromised patient [in French]. Ann Dermatol Venereol. 2001;128:130-133.
11. Yoshimoto T, Yagi K, Inoue M, et al. Leukoencephalopathy probably caused by tacrolimus hydrate after stem cell transplantation in a girl with MDS 7 monosomy [in Japanese]. Rinsho Ketsueki. 1997;38:616-621.
12. Singh N, Gayowski T, Wagener MM, et al. Clinical spectrum of invasive cryptococcosis in liver transplant recipients receiving tacrolimus. Clin Transplant. 1997;11:66-70.
13. Kikuchi K, Tagami H. Comparison of the effects of daily applications between topical corticosteroid and tacrolimus ointments on normal skin: evaluation with noninvasive methods. Dermatology. 2002;205:378-382.
14. Reitamo S, Rustin M, Ruzicka T, et al, and the European Tacrolimus Ointment Study Group. Efficacy and safety of tacrolimus ointment compared with that of hydrocortisone butyrate ointment in adult patients with atopic dermatitis. J Alkrgy Clin Immunol. 2002;109:547-555.
15. Reitamo S, Van Leent EJ, Ho V, et al. Efficacy and safety of tacrolimus ointment compared with that of hydrocortisone acetate ointment in children with atopic dermatitis. J Allergy Clin Immunol. 2002;109:539-546.
16. Schnopp C, Remling R, Mohrenschlager M, et al. Topical tacrolimus (FK506) and mometasone furoate in treatment of dyshidrotic palmar eczema: a randomized, observer-blinded trial. J Am Acad Dermatol. 2002;46:73-77.
17. Torok HM, Maas-Irslinger R, Slayton RM. Clocortolone pivalate cream 0.1% used concomitantly with tacrolimus ointment 0.1% in atopic dermatitis. Cutis. 2003;72:161-166.